Countries
Beneficiaries
from Academia and Industry
Partner Organizations
from Academia and Industry
ESR positions

Welcome to ALLODD

The ALLOstery in Drug Discovery (ALLODD) project is a collaboration between 13 academic and industrial organizations with 14 ESR/PhD students available positions. The aim of ALLODD is to train a new generation of scientists to exploit the concept of allostery in drug design, putting together a whole array of technologies to identify and characterize allosteric modulators of protein function that will be applied to therapeutically relevant systems.

Beneficiaries

Partner Organizations
13 academic and industrial organizations from
10 different countries​

Open Positions

You want to participate in a training program in and beyond the fields of physical chemistry of biological systems, theoretical and computational chemistry, biological chemistry, biochemistry, targeted drug delivery/discovery and medicinal chemistry?

14 Early Stage Researcher (ESR) positions are available within the EU-funded Marie Skłodowska Curie Innovative Training Network on Allostery in Drug Discovery (ALLODD) under Grant Agreement No. 956314.

If you want to apply, click here.
11 academic and industrial
partner organizations from
9 different countries

Training

ALLODD aims to provide young Researchers (Early Stage Researchers-ESRs) with dedicated and multidisciplinary training.
  • Each ESR will have at least 2 secondments in industry and academia.
  • In the scope of Network-wide training, there will be workshops, webinars and 3 ALLODD Network weeks, with training schools and workshops, to enrich the ESRs' scientific and transferable skills.
  • Local training, with specialized courses and seminars.
Allostery is the second secret of life.
Jacques Monod (1960)
Find out more
about ALLODD.
Vertical Divider
Contact us.
You can contact us here.
Vertical Divider
Follow us on Twitter!
You can follow ALLODD on Twitter.
@ALLODD_ITN
This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 956314.
Disclaimer | Privacy Policy